Brivaracetam Intermediate Resolution Without Chiral Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing brivaracetam are costly and lack industrial applicability due to the reliance on chiral chromatographic columns and inefficient resolution of diastereomers, leading to low yields and poor chiral purity.
Innovation Solution
A method involving the use of (1S,2S)-(+)-1,2-cyclohexanediamine and related compounds as resolving reagents, coupled with specific solvent systems and crystallization techniques, to resolve and purify brivaracetam intermediates, avoiding the need for chiral chromatography.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If chiral chromatographic column is used to separate diastereomers, then chiral purity is improved, but production cost increases and device complexity increases
Solution Approach 1:
The patent extracts the chiral separation function from the complex chiral chromatographic column system and transfers it to a simple chemical resolving agent ((1S,2S)-(+)-1,2-cyclohexanediamine). The resolving agent selectively reacts with diastereomers to form compounds with different solubilities, enabling separation through simple filtration without requiring complex chromatographic equipment.
Solution Approach 2:
The patent replaces the mechanical/physical chiral chromatographic separation system with a chemical reaction-based resolution system. Instead of using physical adsorption and elution mechanisms of chromatography, the invention uses chemical derivatization with a resolving agent followed by solubility-based separation, thereby eliminating the need for expensive and complex chromatographic columns.
2Manufacturing precision
If chiral chromatographic column is used to separate diastereomers, then chiral purity is improved, but production cost increases
Solution Approach 1:
The patent employs a inexpensive chemical resolving agent ((1S,2S)-(+)-1,2-cyclohexanediamine) that can be used in stoichiometric or sub-stoichiometric amounts and then removed or recycled. This disposable-like chemical approach replaces the expensive, reusable but costly-to-maintain chiral chromatographic columns, significantly reducing production costs while achieving the same chiral purification goal.
3Device complexity
If R-phenethylamine/isopropanol system is used to resolve diastereomers, then chiral chromatography is avoided, but yield is reduced and resolving effect is poor
Solution Approach 1:
The patent optimizes key parameters of the resolution process including the structure of the resolving agent ((1S,2S)-(+)-1,2-cyclohexanediamine with specific R1, R2, R3 substituents), the solvent system, temperature, and reaction conditions. These parameter optimizations enhance the differential solubility of the diastereomeric complexes, improving both the efficiency of separation and the yield of the desired product compared to the R-phenethylamine system.
4Manufacturing precision
If existing resolution methods are used, then chiral purity is improved, but process complexity increases and industrial applicability decreases
Solution Approach 1:
The patent introduces local quality through the specific substituents (R1, R2, R3) on the cyclohexanediamine resolving agent, where at least one is a tosyl group (Ts). This localized functional group provides specific interaction with the diastereomers, enhancing selectivity and resolution efficiency. The method achieves high chiral purity through this localized chemical property rather than through complex overall process design, improving industrial applicability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves yield and chiral purity, reduces production costs, and simplifies the process, making it suitable for industrial production.
Implementation Method 1
reacting a compound represented by Formula B-P with a resolving reagent to obtain a compound represented by Formula B-Q
Implementation Method 2
The inventors of the present application conducted an in-depth study and found that some of the resolving reagents reported in the prior art, such as R-phenethylamine and the like cannot achieve the resolving of the compound represented by B-P. However, in the process of further exploration, the inventors unexpectedly found that the specific resolving reagent as described above can effectively resolve the brivaracetam intermediate represented by Formula B-R from the compound represented by Formula B-P
Data Source
AI summary
Disclosed is a method for preparing a brivaracetam intermediate shown in formula B—R, comprising: reacting a compound shown in formula B—P and a resolving agent to prepare a compound shown in formula B-Q; and converting the compound shown in formula B-Q into the brivaracetam intermediate shown in formula B—R, wherein the resolving agent is a (1S,2S)-(+)-1,2-diaminocyclohexane compound. Also provided is a method for preparing brivaracetam. According to the method, a mixture of two diastereoisomers of(S)-2-3-propylpyrrolidine-1-yl butyric acid can be conveniently and effectively resolved, and the use of a chiral HPLC column is avoided, thereby greatly shortening the process time, simplifying the operation, reducing the process cost, and facilitating industrial production and environmental protection.